|
WO2021040570A1
|
|
Medicament and method for treating infectious diseases
|
|
EP3796936A1
|
|
A drug for treating disorders of an organ or tissue function and diseases accompanied by such disorders, and the method for obtaining it
|
|
GB201820538D0
|
|
Apparatus and method for measuring a gas
|
|
EA030610B1
|
|
Method for determining modifying activity
|
|
FI20135145A
|
|
Combination pharmaceutical composition and methods for the treatment of diseases or conditions related to the cardiovascular system
|
|
US2013171161A1
|
|
Method and composition for the treatment of diseases caused by or associated with hiv
|
|
CN103119061A
|
|
A method of treating attention deficit hyperactivity disorder
|
|
MX2013000543A
|
|
Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract.
|
|
UA112748C2
|
|
Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
|
|
KR20140012009A
|
|
Pharmaceutical compositions and methods of treatment
|
|
CA2804967A1
|
|
Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
|
|
CN103108657A
|
|
A method of increasing the effect of an activated-potentiated form of an antibody
|
|
EA029847B1
|
|
Combination pharmaceutical composition and method of treating diabetes mellitus and associated metabolic disorders
|
|
CN103096927A
|
|
Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
|
|
AU2011281252A1
|
|
A method of treating Alzheimer's disease
|
|
MX2013000547A
|
|
Combination pharmaceutical composition and methods of treating genitourinary system disorders.
|
|
FR2963562A1
|
|
Pharmaceutical composition and use thereof in a process for inhibiting production of or amplifying the elimination of p24 protein
|
|
AU2011287292A1
|
|
Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
|
|
CA2804969A1
|
|
A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system
|
|
UA112757C2
|
|
A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders
|
